Identification of a Six-Gene Prognostic Signature Characterized by Tumor Microenvironment Immune Profiles in Clear Cell Renal Cell Carcinoma
Clear cell renal cell carcinoma (ccRCC) is widely acknowledged to be extremely sensitive to immunotherapy, emphasizing the tremendous impacts on which the tumor microenvironment (TME) has shown. However, the molecular subgroups characterized by the TME features scarcely serve as the risk stratificat...
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fca34c9ea4894a53b07da0f527e1a895 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:fca34c9ea4894a53b07da0f527e1a895 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:fca34c9ea4894a53b07da0f527e1a8952021-11-18T08:14:00ZIdentification of a Six-Gene Prognostic Signature Characterized by Tumor Microenvironment Immune Profiles in Clear Cell Renal Cell Carcinoma1664-802110.3389/fgene.2021.722421https://doaj.org/article/fca34c9ea4894a53b07da0f527e1a8952021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fgene.2021.722421/fullhttps://doaj.org/toc/1664-8021Clear cell renal cell carcinoma (ccRCC) is widely acknowledged to be extremely sensitive to immunotherapy, emphasizing the tremendous impacts on which the tumor microenvironment (TME) has shown. However, the molecular subgroups characterized by the TME features scarcely serve as the risk stratification guides in clinical practice for survival outcomes and immunotherapy response prediction. This study generated fresh insights into a novel TME-related prognostic signature derived from The Cancer Genome Atlas database using integrated bioinformatics analyses. Subsequently, Kaplan–Meier survival analysis, receiver operating characteristic analysis, and univariate and multivariate Cox regression analysis were performed to evaluate and validate the efficacy and the accuracy of the signature in ccRCC prognosis. Furthermore, we discovered that the risk score presented an increased likelihood of correlation with miscellaneous clinicopathological characteristics, natural killer cell-mediated cytotoxicity, immune cell infiltration levels, and immune checkpoint expression. These findings highlighted the notion that the six-gene signature characterized by the TME features may have implications on the risk stratification for personalized and precise immunotherapeutic management.Lu ZhangJianlong LiMengzhao ZhangLu WangTao YangQiuya ShaoXiao LiangMinghai MaNan ZhangMinxuan JingRundong SongJinhai FanJinhai FanFrontiers Media S.A.articlegene signaturetumor microenvironmenttumor-infiltrating immune cellsimmunotherapyclear cell renal cell carcinomaGeneticsQH426-470ENFrontiers in Genetics, Vol 12 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
gene signature tumor microenvironment tumor-infiltrating immune cells immunotherapy clear cell renal cell carcinoma Genetics QH426-470 |
spellingShingle |
gene signature tumor microenvironment tumor-infiltrating immune cells immunotherapy clear cell renal cell carcinoma Genetics QH426-470 Lu Zhang Jianlong Li Mengzhao Zhang Lu Wang Tao Yang Qiuya Shao Xiao Liang Minghai Ma Nan Zhang Minxuan Jing Rundong Song Jinhai Fan Jinhai Fan Identification of a Six-Gene Prognostic Signature Characterized by Tumor Microenvironment Immune Profiles in Clear Cell Renal Cell Carcinoma |
description |
Clear cell renal cell carcinoma (ccRCC) is widely acknowledged to be extremely sensitive to immunotherapy, emphasizing the tremendous impacts on which the tumor microenvironment (TME) has shown. However, the molecular subgroups characterized by the TME features scarcely serve as the risk stratification guides in clinical practice for survival outcomes and immunotherapy response prediction. This study generated fresh insights into a novel TME-related prognostic signature derived from The Cancer Genome Atlas database using integrated bioinformatics analyses. Subsequently, Kaplan–Meier survival analysis, receiver operating characteristic analysis, and univariate and multivariate Cox regression analysis were performed to evaluate and validate the efficacy and the accuracy of the signature in ccRCC prognosis. Furthermore, we discovered that the risk score presented an increased likelihood of correlation with miscellaneous clinicopathological characteristics, natural killer cell-mediated cytotoxicity, immune cell infiltration levels, and immune checkpoint expression. These findings highlighted the notion that the six-gene signature characterized by the TME features may have implications on the risk stratification for personalized and precise immunotherapeutic management. |
format |
article |
author |
Lu Zhang Jianlong Li Mengzhao Zhang Lu Wang Tao Yang Qiuya Shao Xiao Liang Minghai Ma Nan Zhang Minxuan Jing Rundong Song Jinhai Fan Jinhai Fan |
author_facet |
Lu Zhang Jianlong Li Mengzhao Zhang Lu Wang Tao Yang Qiuya Shao Xiao Liang Minghai Ma Nan Zhang Minxuan Jing Rundong Song Jinhai Fan Jinhai Fan |
author_sort |
Lu Zhang |
title |
Identification of a Six-Gene Prognostic Signature Characterized by Tumor Microenvironment Immune Profiles in Clear Cell Renal Cell Carcinoma |
title_short |
Identification of a Six-Gene Prognostic Signature Characterized by Tumor Microenvironment Immune Profiles in Clear Cell Renal Cell Carcinoma |
title_full |
Identification of a Six-Gene Prognostic Signature Characterized by Tumor Microenvironment Immune Profiles in Clear Cell Renal Cell Carcinoma |
title_fullStr |
Identification of a Six-Gene Prognostic Signature Characterized by Tumor Microenvironment Immune Profiles in Clear Cell Renal Cell Carcinoma |
title_full_unstemmed |
Identification of a Six-Gene Prognostic Signature Characterized by Tumor Microenvironment Immune Profiles in Clear Cell Renal Cell Carcinoma |
title_sort |
identification of a six-gene prognostic signature characterized by tumor microenvironment immune profiles in clear cell renal cell carcinoma |
publisher |
Frontiers Media S.A. |
publishDate |
2021 |
url |
https://doaj.org/article/fca34c9ea4894a53b07da0f527e1a895 |
work_keys_str_mv |
AT luzhang identificationofasixgeneprognosticsignaturecharacterizedbytumormicroenvironmentimmuneprofilesinclearcellrenalcellcarcinoma AT jianlongli identificationofasixgeneprognosticsignaturecharacterizedbytumormicroenvironmentimmuneprofilesinclearcellrenalcellcarcinoma AT mengzhaozhang identificationofasixgeneprognosticsignaturecharacterizedbytumormicroenvironmentimmuneprofilesinclearcellrenalcellcarcinoma AT luwang identificationofasixgeneprognosticsignaturecharacterizedbytumormicroenvironmentimmuneprofilesinclearcellrenalcellcarcinoma AT taoyang identificationofasixgeneprognosticsignaturecharacterizedbytumormicroenvironmentimmuneprofilesinclearcellrenalcellcarcinoma AT qiuyashao identificationofasixgeneprognosticsignaturecharacterizedbytumormicroenvironmentimmuneprofilesinclearcellrenalcellcarcinoma AT xiaoliang identificationofasixgeneprognosticsignaturecharacterizedbytumormicroenvironmentimmuneprofilesinclearcellrenalcellcarcinoma AT minghaima identificationofasixgeneprognosticsignaturecharacterizedbytumormicroenvironmentimmuneprofilesinclearcellrenalcellcarcinoma AT nanzhang identificationofasixgeneprognosticsignaturecharacterizedbytumormicroenvironmentimmuneprofilesinclearcellrenalcellcarcinoma AT minxuanjing identificationofasixgeneprognosticsignaturecharacterizedbytumormicroenvironmentimmuneprofilesinclearcellrenalcellcarcinoma AT rundongsong identificationofasixgeneprognosticsignaturecharacterizedbytumormicroenvironmentimmuneprofilesinclearcellrenalcellcarcinoma AT jinhaifan identificationofasixgeneprognosticsignaturecharacterizedbytumormicroenvironmentimmuneprofilesinclearcellrenalcellcarcinoma AT jinhaifan identificationofasixgeneprognosticsignaturecharacterizedbytumormicroenvironmentimmuneprofilesinclearcellrenalcellcarcinoma |
_version_ |
1718422085075730432 |